Medical Condition News

RSS

Declining kidney function linked to higher risk of heart failure in individuals with or without kidney disease

Declining kidney function is linked to a higher risk of heart failure, heart attack, peripheral arterial disease, and early death in individuals with or without kidney disease, according to a pair of studies appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

6 Nov 2009

Exposure to higher levels of air pollution increases infants' risk for bronchiolitis

Infants who are exposed to higher levels of air pollution are at increased risk for bronchiolitis, according to a new study.

6 Nov 2009

Prevalence of lactose intolerance may be far lower than previously estimated, says study

Prevalence of lactose intolerance may be far lower than previously estimated, according to a study in the latest issue of Nutrition Today. The study, which uses data from a national sample of three ethnic groups, reveals that the overall prevalence rate of self-reported lactose intolerance is 12 percent - with 7.72 percent of European Americans, 10.05 percent of Hispanic Americans and 19.5 percent of African Americans who consider themselves lactose intolerant.

6 Nov 2009

Higher levels of phosphorus in blood linked to increased calcification of coronary arteries, says study

Higher levels of phosphorus in the blood are linked to increased calcification of the coronary arteries— a key marker of heart disease risk, according to a study in an upcoming issue of Clinical Journal of the American Society of Nephrology (CJASN). "This may help to explain why even early-stage chronic kidney disease (CKD) is associated with increased cardiovascular risk that is not otherwise explained by traditional risk factors," comments Katherine R. Tuttle, MD (Providence Medical Research Center, Spokane, WA).

6 Nov 2009

Scientists identify new behavioral traits of immune cells; findings may help in understanding complex diseases

In diseases such as multiple sclerosis, cells of the immune system infiltrate the brain tissue, where they cause immense damage. For many years, it was an enigma as to how these cells can escape from the bloodstream. This is no trivial feat, given that specialized blood vessels act as a barrier between the nervous system and the bloodstream.

6 Nov 2009

Rice University's new BRC awarded $2M NIH grant to develop an inexpensive test for oral cancer

The National Institutes of Health (NIH) has awarded researchers in Rice University's new BioScience Research Collaborative (BRC) a $2 million Grand Opportunity (GO) grant to develop a fast, inexpensive test for oral cancer that a dentist could perform simply by using a brush to collect a small sample of cells from a patient's mouth.

6 Nov 2009

Bortezomib lymphoma drug may be effective against bone cancer in children and teens: Study

A drug already approved for the treatment of lymphoma may also slow the growth of the most deadly bone cancer in children and teens, according to an early-stage study published online today in the International Journal of Cancer.

5 Nov 2009

Amgen announces the results for Phase 3 PRIME '203' trial of Vectibix

Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.

5 Nov 2009

FDA clears ARKRAY's new GLUCOCARD Vital blood glucose monitoring system

ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.

5 Nov 2009

FDA grants Abraxis BioScience orphan drug designation for ABRAXANE

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma.

5 Nov 2009

ARIAD Pharmaceuticals' SUCCEED trial of oral ridaforolimus on track

ARIAD Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009 and provided an update on corporate developments.

5 Nov 2009

New biosensor device may help in combating cancer

A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.

5 Nov 2009

STMicroelectronics and Mayo Clinic collaborate on a novel heart-monitoring platform

STMicroelectronics, one of the world's leading semiconductor companies, and Mayo Clinic, a premier health-care organization, are collaborating on a novel platform for remotely monitoring patients with chronic cardiovascular disease.

5 Nov 2009

New laser therapy for cataract treatment

A new laser therapy that can potentially remove cataracts from people's eyes more efficiently and with greater precision was presented on October 24, 2009 at the American Academy of Ophthalmology (AAO) annual meeting.

5 Nov 2009

Limitations of prevalence estimates of TBI and PTSD among OIF/OEF veterans discussed

In a special guest editorial, Bass and colleagues discuss the limitations of current estimates of the prevalence of traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) among Operation Iraqi Freedom and Operation Enduring Freedom (OIF/OEF) veterans. Since these estimates often determine the allocation of resources, the authors urge decision makers to understand the limitations of these prevalence estimates.

5 Nov 2009

Food advertising aimed at children contributes to obesity

Childhood obesity in the United States is reaching epidemic proportions. With more than one fourth of advertising on daytime and prime time television devoted to foods and beverages and continuing questions about the role television plays in obesity, a study in the November/December issue of the Journal of Nutrition Education and Behavior examines how food advertising aimed at children might be a large contributor to the problem.

5 Nov 2009

NIST researchers to develop a certified reference material to assess C-reactive protein

Searching for a needle in a haystack may seem futile, but it's worth it if the needle is a hard-to-detect protein that may identify a person at high risk of a heart attack circulating within a haystack of human serum (liquid component of blood).

5 Nov 2009

Abraxis Health dedicates its new manufacturing facility in Phoenix

Abraxis Health, a fully-integrated personalized healthcare division of Abraxis BioScience, Inc., today announced the dedication of its new manufacturing facility in Phoenix, Arizona. The state of the art biopharma manufacturing plant represents a $70 million investment by LA-based Abraxis, and will create up to 200 high tech jobs.

5 Nov 2009

Asthma in 9/11 responders is two times greater than general US population

Responders to the 2001 World Trade Center (WTC) terrorist attacks, who were exposed to caustic dust and toxic pollutants following the 9/11 disaster, suffer from asthma at a rate more than twice that of the general US population, according to new research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP).

5 Nov 2009

Scientists identify a novel cellular source of atrial fibrillation

While studying how the heart is formed, scientists at the University of Pennsylvania School of Medicine serendipitously found a novel cellular source of atrial fibrillation (AF), the most common type of abnormal heart beat.

5 Nov 2009

Medical Condition News

Declining kidney function linked to higher risk of heart failure in individuals with or without kidney disease

Exposure to higher levels of air pollution increases infants' risk for bronchiolitis

Prevalence of lactose intolerance may be far lower than previously estimated, says study

Higher levels of phosphorus in blood linked to increased calcification of coronary arteries, says study

Scientists identify new behavioral traits of immune cells; findings may help in understanding complex diseases

Rice University's new BRC awarded $2M NIH grant to develop an inexpensive test for oral cancer

Bortezomib lymphoma drug may be effective against bone cancer in children and teens: Study

Amgen announces the results for Phase 3 PRIME '203' trial of Vectibix

FDA clears ARKRAY's new GLUCOCARD Vital blood glucose monitoring system

FDA grants Abraxis BioScience orphan drug designation for ABRAXANE

ARIAD Pharmaceuticals' SUCCEED trial of oral ridaforolimus on track

New biosensor device may help in combating cancer

STMicroelectronics and Mayo Clinic collaborate on a novel heart-monitoring platform

New laser therapy for cataract treatment

Limitations of prevalence estimates of TBI and PTSD among OIF/OEF veterans discussed

Food advertising aimed at children contributes to obesity

NIST researchers to develop a certified reference material to assess C-reactive protein

Abraxis Health dedicates its new manufacturing facility in Phoenix

Asthma in 9/11 responders is two times greater than general US population

Scientists identify a novel cellular source of atrial fibrillation

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News